[ Genoa Pharmaceuticals raises $62M in Series A ]

Genoa Pharmaceuticals has raised $62 million in Series A funding.

Founded in 2011, Genoa Pharmaceuticals  is a biopharma firm that develops therapies for the treatment of idiopathic pulmonary fibrosis and respiratory diseases.Genoa’s lead program (Aerodone™; inhaled pirfenidone) is on track to enter clinical development by year’s end

With this financing and its veteran development team, the company  has the funds and expertise to test Aerodone™ for the treatment of IPF through Phase 2 clinical trials.

Funding  Series A
Founded  2011
Country  USA
City  Seattle, Washington
Founder / CEO  Bruce Montgomery
Deal Size  $62M
Investors  TPG Biotech
 Novo A/S
 Edmond de Rothschild Investment  Partners
 F-Prime Capital Partners
Previous Investors  /